Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on IDO1 Inhibitors. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel C-H activation synthesis of high-B-ring berberine derivatives offers potent IDO1/TDO inhibition for oncology drug development.